News
Viral Hepatitis Special Interest Group supports national response to eliminate hepatitis B and hepatitis C by 2030 28 July 2022
Viral Hepatitis Special Interest Group supports national response to eliminate hepatitis B and hepatitis C by 2030 28 July 2022
ASID Special Interest Groups support ATAGI advice on COVID-19 vaccinations for children aged 6 months to <5 years old in Australia.
ASID Special Interest Groups support ATAGI advice on COVID-19 vaccinations for children aged 6 months to <5 years old in Australia
All children over six months of age should get the influenza vaccine: Australian and New Zealand Paediatric Infectious Diseases Group
The Australian and New Zealand Paediatric Infectious Diseases Group (ANZPID) of the Australasian Society for Infectious Diseases (ASID) strongly supports the recommendations of the Australian Technical Advisory Group on Immunisation (ATAGI) for all children over six months of age to receive the influenza vaccine, which is currently available throughout Australia and Aotearoa/New Zealand.
Vaccination Special Interest Group supports ATAGI recommendations
The Australasian Society for Infectious Diseases (ASID) and its Vaccination Special Interest Group (VACSIG) have strongly supported the recent Australian Technical Advisory Group on Immunisation (ATAGI) recommendations.
ASID welcomes the Australian Government’s commitment to establish a national Centre for Disease Control in Australia
The Australasian Society for Infectious Diseases (ASID) has welcomed the commitment from Prime Minister Anthony Albanese to establish a national Centre for Disease Control (CDC) in Australia.
Leading Western Australian paediatric infectious diseases specialist honoured with Frank Fenner Award
Associate Professor Asha Bowen has been awarded the 2022 Frank Fenner Award for Advanced Research in Infectious Diseases.
The Australian and New Zealand Paediatric Infectious Diseases Group (ANZPID) supports efforts to prioritise access to education for children and young people.
This important but challenging priority will need effective leadership and child-focussed decision making at all levels of government. Children, families and teachers need clear and equitable guidelines for maintaining safe face-to-face education during COVID as well as access to rapid testing and online educational options where necessary.
Updated ANZPID Statement on Primary School aged (5-to 11-year-olds) children and COVID vaccines
The Australian and New Zealand Paediatric Infectious Diseases Group (ANZPID) of the Australasian Society for Infectious Diseases (ASID) supports the Therapeutic Goods Administration (TGA) and Australian Technical Advisory Group on Immunisation (ATAGI) advice on COVID vaccinations for 5-to 11-year-olds in Australia, following their review of safety and efficacy data on these vaccines in children.
Joint Statement with the Australian and New Zealand Society of Nephrology (ANZSN) - Vaccination against COVID-19 for Adult Patients with Kidney Failure Requiring Transplantation or Dialysis
The Australian and New Zealand Society of Nephrology (ANZSN) and the Australasian
Society for Infectious Diseases (ASID) strongly recommend that adult patients with kidney
failure requiring dialysis or transplantation are vaccinated against COVID-19, using any of the available vaccines that have been approved by the TGA and endorsed by ATAGI, or approved by Medsafe and in accordance with New Zealand Ministry of Health Guidelines.
Joint Statement with the New Zealand Sepsis Trust - COVID-19 exacerbates the existing burden of sepsis on the healthcare system
The solutions are there to reduce inequity and unnecessary harm, and must be urgently embraced through the government’s health reforms. That’s the key message from the upcoming New Zealand Sepsis Conference 2021 and the newly revised National Sepsis Action Plan.